Journal article
What Is the Economic Value of Digoxin Therapy in Congestive Heart Failure Patients? Results From the DIG Trial
Abstract
BACKGROUND: The Digitalis Investigation Group (DIG) clinical train randomized 6800 congestive heart failure patients (ejection fraction > or =45%) to a daily regimen of either digoxin or placebo. At 37 months average follow-up, patients in both groups had similar mortality. We determined the incremental costs associated with the use of digoxin in this high-risk population.
METHODS AND RESULTS: Hospitalizations and medical costs were compared by …
Authors
Eisenstein EL; Yusuf S; Bindal V; Bourassa MG; Horney A; Collins JF; Mark DB; investigators OBOTD
Journal
Journal of Cardiac Failure, Vol. 12, No. 5, pp. 336–342
Publisher
Elsevier
Publication Date
6 2006
DOI
10.1016/j.cardfail.2006.04.002
ISSN
1071-9164